Pasar al contenido principal

PLATAFORMAS MULTIMODALES PARA LA REGENERACION DE LA MUCOSA ORAL TRAS UNA RESECCION TUMORAL

PID2021-128412OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Engineering Poly(lactic Acid)-Based Scaffolds for Abundant, Sustained, and Prolonged Lactate Release

  • Haro Gutiérrez, Pilar A.
  • Colombi, Samuele
  • Casanovas Salas, Jordi
  • Resina, Leonor
  • Sans, Jordi
  • Engel, Elisabeth
  • Enshaei, Hamidreza
  • García-Torres, José
  • Pérez-Madrigal, Maria M.
  • Alemán, Carlos
Recent studies have revealed that cardiac tissue regeneration is promoted by administering an initial dose of exogenous lactate and locally maintaining an abundant concentration of this compound for a prolonged period (i.e., around 10–14 days) through sustained release. The aim of this study is to develop a scaffold based on poly(lactic acid) (PLA) for achieving a sustained daily release of lactate from the first day to the end of the recommended period. First, a five-layered electroresponsive scaffold has been engineered using three PLA layers (first, third, and fifth), each composed of electrospun microfibers (MFs), separated by spin coated lactate (second) and poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) (PEDOT:PSS) (fourth) intermediate layers. The hydrophobicity of the outer PLA layers (first and fifth) has been used to maintain the release of lactate from the intermediate second layer over 3 days, while the conducting fourth PEDOT:PSS layer has ensured a complete lactate release by electrostimulation. After that, in a second step, the same scaffold has been re-engineered to maintain the sustained release not only for a short period (3 days) but also for a prolonged period (>10 days). For this purpose, the PLA MFs of the intermediate third layer have been substituted by plasma-treated proteinase K-containing PLA MFs, obtained by electrospinning a PLA:enzyme mixture. The activity of the enzyme, which decomposes the ester bonds of PLA, combined with the effect of the plasma on the PLA structure, results in a prolonged sustained release that, in addition, can be modulated., This publication is part of the I+D+i projects PID2021-125767OB-I00, PLEC2022-009279, PID2021-128412OB-I00, PDC2022-133755-I00, and CEX2023-001300-M funded by MCIN/AEI/10.13039/501100011033 and, as appropriate, by “ERDF A way of making Europe” and European Union Next Generation EU (REGOMUC and BIOMATCH projects). The authors thank the Agencia ̀ de Gestió d’Ajuts Universitaris i de Recerca (2021 SGR 00387) for financial support. P.A.H.-G. thanks CONACYT (México) for the financial support through a postgraduate scholarship (836603 CVU 347614). S.C. thanks the Agencia ̀ de Gestió d’Ajuts Universitaris i de Recerca (AGAUR; Generalitat de Catalunya) for a FI Fellowship. E.E. received funding from the CERCA program by the Generalitat de Catalunya and the ″Centro de Excelencia Severo Ochoa″ (grant CEX2023-001282-S, funded by MICIU/AEI/10.13039/ 501100011033). M.M.P.-M. thanks the Ministerio de Ciencia, Innovación y Universidades for the Junior Beatriz Galindo Award (BG20/00216). J.G.-T. acknowledges the Serra Hunter program of the Generalitat de Catalunya. Support for the research of E.E. and C.A. was also received through the prize “ICREA Academia” for excellence in research funded by the Generalitat de Catalunya.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

3D Printing as a Strategy to Scale-Up Biohybrid Hydrogels for T Cell Manufacture

  • Pérez Del Río, Eduardo
  • Rey Vinolas, Sergi
  • Santos, Fabião
  • Castellote Borrell, Miquel
  • Merlina, Francesca
  • Veciana, Jaume
  • Ratera, Immaculada
  • Mateos Timoneda, Miguel A.
  • Engel, Elisabeth
  • Guasch, Judith
The emergence of cellular immunotherapy treatments is introducing more efficient strategies to combat cancer as well as autoimmune and infectious diseases. However, the cellular manufacturing procedures associated with these therapies remain costly and time-consuming, thus limiting their applicability. Recently, lymph-node-inspired PEG-heparin hydrogels have been demonstrated to improve primary human T cell culture at the laboratory scale. To go one step further in their clinical applicability, we assessed their scalability, which was successfully achieved by 3D printing. Thus, we were able to improve primary human T cell infiltration in the biohybrid PEG-heparin hydrogels, as well as increase nutrient, waste, and gas transport, resulting in higher primary human T cell proliferation rates while maintaining the phenotype. Thus, we moved one step further toward meeting the requirements needed to improve the manufacture of the cellular products used in cellular immunotherapies., This research was funded by the Spanish Ministry of Science and Innovation (PID2020-115296RA-I00; PID2019-105622RB-I00; PID2021-128412OB-I00 European Union NextGenerationEU/PRTR, and the “Ramón y Cajal” program (RYC-2017-22614)) as well as the Generalitat de Catalunya (SGRCat 2021-00438; 2017-SGR-359; Tecnologies Emergents program of the General Directorate for Research – Nr. 001-P-001646, cofunded with FEDER Operational Program of Catalonia 2014–2020). The work was also supported by the Max Planck Society through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy” in collaboration with the Max Planck Institute for Medical Research (Heidelberg, Germany). The authors are grateful for the financial support received from Instituto de Salud Carlos III through Consorcio Centro de Investigación Biomédica en Red (CIBER) with the project “Gels4ACT” (Nr. BBN20PIV02). This research was also supported by the European Union’s Horizon 2020 research and innovation program H2020-MSCA-COFUND-2016 (DOC-FAM, grant agreement Nr. 754397). The authors acknowledge financial support from the Spanish Ministry of Science and Innovation through the “Severo Ochoa” Program for Centres of Excellence in R&D (CEX2023-001263-S, CEX2019-000917-S and CEX2018-000789-S)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S). With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2023-001263-S)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Engineering Poly(lactic Acid)-Based Scaffolds for Abundant, Sustained, and Prolonged Lactate Release

  • Haro Gutiérrez, Pilar A.
  • Colombi, Samuele
  • Casanovas Salas, Jordi
  • Resina, Leonor
  • Sans, Jordi
  • Engel, Elisabeth
  • Enshaei, Hamidreza
  • García-Torres, José
  • Pérez-Madrigal, Maria M.
  • Alemán, Carlos
Recent studies have revealed that cardiac tissue regeneration is promoted by administering an initial dose of exogenous lactate and locally maintaining an abundant concentration of this compound for a prolonged period (i.e., around 10–14 days) through sustained release. The aim of this study is to develop a scaffold based on poly(lactic acid) (PLA) for achieving a sustained daily release of lactate from the first day to the end of the recommended period. First, a five-layered electroresponsive scaffold has been engineered using three PLA layers (first, third, and fifth), each composed of electrospun microfibers (MFs), separated by spin coated lactate (second) and poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) (PEDOT:PSS) (fourth) intermediate layers. The hydrophobicity of the outer PLA layers (first and fifth) has been used to maintain the release of lactate from the intermediate second layer over 3 days, while the conducting fourth PEDOT:PSS layer has ensured a complete lactate release by electrostimulation. After that, in a second step, the same scaffold has been re-engineered to maintain the sustained release not only for a short period (3 days) but also for a prolonged period (>10 days). For this purpose, the PLA MFs of the intermediate third layer have been substituted by plasma-treated proteinase K-containing PLA MFs, obtained by electrospinning a PLA:enzyme mixture. The activity of the enzyme, which decomposes the ester bonds of PLA, combined with the effect of the plasma on the PLA structure, results in a prolonged sustained release that, in addition, can be modulated., This publication is part of the I+D+i projects PID2021-125767OB-I00, PLEC2022-009279, PID2021-128412OB-I00, PDC2022-133755-I00, and CEX2023-001300-M funded by MCIN/AEI/10.13039/501100011033 and, as appropriate, by “ERDF A way of making Europe” and European Union Next Generation EU (REGOMUC and BIOMATCH projects). The authors thank the Agencia ̀ de Gestió d’Ajuts Universitaris i de Recerca (2021 SGR 00387) for financial support. P.A.H.-G. thanks CONACYT (México) for the financial support through a postgraduate scholarship (836603 CVU 347614). S.C. thanks the Agencia ̀ de Gestió d’Ajuts Universitaris i de Recerca (AGAUR; Generalitat de Catalunya) for a FI Fellowship. E.E. received funding from the CERCA program by the Generalitat de Catalunya and the ″Centro de Excelencia Severo Ochoa″ (grant CEX2023-001282-S, funded by MICIU/AEI/10.13039/ 501100011033). M.M.P.-M. thanks the Ministerio de Ciencia, Innovación y Universidades for the Junior Beatriz Galindo Award (BG20/00216). J.G.-T. acknowledges the Serra Hunter program of the Generalitat de Catalunya. Support for the research of E.E. and C.A. was also received through the prize “ICREA Academia” for excellence in research funded by the Generalitat de Catalunya.